Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Knowler

Showing results (171-180 of 345) with videos related to

Pageof 35
Sort By:
JAMA Network Open|September 12, 2022
Effects of a Diabetes Prevention Program on Type 2 Diabetes Risk Factors and Quality of Life Among Latino Youths With Prediabetes: A Randomized Clinical TrialArmando Peña, Micah L Olson, Elva Hooker, et al.
Diabetes Care|August 7, 2015
Environmentally Driven Increases in Type 2 Diabetes and Obesity in Pima Indians and Non-Pimas in Mexico Over a 15-Year Period: The Maycoba ProjectJulian Esparza-Romero, Mauro E Valencia, Rene Urquidez-Romero, et al.
Vascular Medicine (London, England)|August 9, 2008
Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes studyMark A Espeland, Judith G Regensteiner, Sarah A Jaramillo, et al.
Diabetes Care|May 20, 2011
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetesRena R Wing, Wei Lang, Thomas A Wadden, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2018
Identification and functional analysis of a novel G310D variant in the insulin-like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in American IndiansYunhua L Muller, Graham Skelton, Paolo Piaggi, et al.
Controlled Clinical Trials|September 23, 2003
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetesDonna H Ryan, Mark A Espeland, Gary D Foster, et al.
Diabetes/Metabolism Research and Reviews|July 18, 2006
Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetesHelen C Looker, Anne Fagot-Campagna, Elaine W Gunter, et al.
Diabetes Care|January 14, 2021
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity MeasuresAndrea M Kriska, Bonny Rockette-Wagner, Sharon L Edelstein, et al.
Diabetologia|October 11, 2025
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes StudyWei Perng, Shiyu Shu, David M Nathan, et al.
Diabetes Care|July 4, 2012
The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Andrew Taylor, et al.
Pageof 35

Showing results (171-180 of 345) with videos related to

Sort By:
Pageof 35
JAMA Network Open|September 12, 2022
Effects of a Diabetes Prevention Program on Type 2 Diabetes Risk Factors and Quality of Life Among Latino Youths With Prediabetes: A Randomized Clinical TrialArmando Peña, Micah L Olson, Elva Hooker, et al.
Diabetes Care|August 7, 2015
Environmentally Driven Increases in Type 2 Diabetes and Obesity in Pima Indians and Non-Pimas in Mexico Over a 15-Year Period: The Maycoba ProjectJulian Esparza-Romero, Mauro E Valencia, Rene Urquidez-Romero, et al.
Vascular Medicine (London, England)|August 9, 2008
Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes studyMark A Espeland, Judith G Regensteiner, Sarah A Jaramillo, et al.
Diabetes Care|May 20, 2011
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetesRena R Wing, Wei Lang, Thomas A Wadden, et al.
Diabetes/Metabolism Research and Reviews|February 23, 2018
Identification and functional analysis of a novel G310D variant in the insulin-like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in American IndiansYunhua L Muller, Graham Skelton, Paolo Piaggi, et al.
Controlled Clinical Trials|September 23, 2003
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetesDonna H Ryan, Mark A Espeland, Gary D Foster, et al.
Diabetes/Metabolism Research and Reviews|July 18, 2006
Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetesHelen C Looker, Anne Fagot-Campagna, Elaine W Gunter, et al.
Diabetes Care|January 14, 2021
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity MeasuresAndrea M Kriska, Bonny Rockette-Wagner, Sharon L Edelstein, et al.
Diabetologia|October 11, 2025
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes StudyWei Perng, Shiyu Shu, David M Nathan, et al.
Diabetes Care|July 4, 2012
The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention ProgramJose C Florez, Kathleen A Jablonski, Andrew Taylor, et al.
Pageof 35